Foley Partner Paul Broude authored an article titled “The IPO Window Is Opening” in the March 2010 issue of MX: Medtech Executive. Broude examines the reasons for a device company to consider an initial public offering for its growth plans, stating that 2010 may bring the promise of IPOs for medical device companies to fund clinical trials, regulatory approvals, and the protection of the company’s intellectual property. He adds that going public enables some medical device and life science companies to continue growing while creating an exit vehicle for management and other shareholders.
Author(s)
Related Insights
Watch On-Demand
Upcoming
Events
Get Anytime Access to Continuing Legal Education and Business Programming
Our new LearningLab: On-Demand Hub offers a growing library of continuing legal education (CLE) and business-focused legal insights you can now access anytime, anywhere.
November 6, 2026
Upcoming
Events
Medicare & Medicaid Administrative Enforcement: Emerging Trends
Foley partner Judy Waltz, chair of the Health Care Practice Group, is speaking in the California Society for Healthcare Attorneys’ upcoming Fall Seminar in the session “Medicare & Medicaid Administrative Enforcement: Emerging Trends.”
October 27, 2026
Upcoming
Events
Federal Administrative Sanctions: Suspensions, Revocations, Exclusions, and Civil Monetary Penalties
Foley partner Judy Waltz, chair of the firm’s Health Care Practice Group, is speaking at the upcoming HCCA Healthcare Enforcement Compliance Conference in the session “Federal Administrative Sanctions: Suspensions, Revocations, Exclusions, and Civil Monetary Penalties.”